Trump considers drug rebate shake-up: 5 things to know

(By Alia Paavola for Becker’s Hospital Review)

The Trump administration is considering a proposal that will remove or alter safe harbor protections for pharmaceutical company rebates — a plan that could reshape how prescription drugs are priced and sold, according to The Wall Street Journal. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.